TOKYO, Nov 12 (Reuters) - Japan's Nikkei share average closed near a 29-1/2-year high on Thursday as technology shares tracked their U.S. peers higher, although gains were checked by profit-booking following a rally fuelled by optimism over COVID-19 vaccine-related developments.
The benchmark Nikkei .N225 settled 0.68% higher at 25,520.88, after hitting its highest level since June 5, 1991 earlier in the session.
Stocks briefly fell into negative territory in afternoon trade, as some investors turned cautious about the rally and booked profits.
"Everybody cheered the vaccine headlines, but they have begun to realise that there are many challenges, such as logistics and vaccine performance," said Daisuke Uchiyama, a senior strategist at Okasan Securities.
An increase in coronavirus cases in Europe and the United States is making it difficult for investors to have an optimistic view about the economic recovery, Uchiyama said.
Overnight, the tech-heavy Nasdaq .IXIC ended 2% higher, after "stay-at-home" stocks bounced back from two straight sessions of sharp losses as investors moved away from economically sensitive sectors back to tech. .N MKT/GLOB
Japan's tech-related shares such as heavyweight SoftBank Group 9984.T benefited from gains in their U.S. counterparts. SoftBank climbed around 1.5%.
Among the top 30 core Topix names, Nintendo 7974.T jumped 4.3% to snap four consecutive sessions of losses.
The broader Topix .TOPX slipped 0.16% to 1,726.23 and snapped seven consecutive sessions of gains. Only eight of the 33 sector sub-indexes on the Tokyo exchange traded higher.
Elsewhere, Isetan Mitsukoshi Holdings 3099.T fell about 5% after it reported a half-year net loss of 36.79 billion yen ($349.48 million). of its department store peers followed suit. Takashimaya 8233.T dropped 4.84%, while J.Front Retailing 3086.T lost 4.68%.
($1 = 105.2700 yen)
Add Chart to Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
- Enrich the conversation
- Stay focused and on track. Only post material that’s relevant to the topic being discussed.
- Be respectful. Even negative opinions can be framed positively and diplomatically.
- Use standard writing style. Include punctuation and upper and lower cases.
- NOTE: Spam and/or promotional messages and links within a comment will be removed
- Avoid profanity, slander or personal attacks directed at an author or another user.
- Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
- Only English comments will be allowed.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.